Muscarinic receptors: a novel therapeutic target for drug addiction

By Yang G.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 12, 2002-12 ,pp. : 551-551

Elsevier

Access to resources Recommend Favorite

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A.   Heilig M.   Rupniak N.M.J.   Steckler T.   Griebel G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders

By Grigoriadis Dimitri E  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 651-684

Informa Healthcare

Access to resources Recommend Favorite

The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 3, 2007-06 ,pp. : 163-182

Bentham Science Publishers

Access to resources Recommend Favorite

Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1770-1786

Bentham Science Publishers

Access to resources Recommend Favorite